Radicava is Now Available for Treatment in U.S

Mitsubishi Tanabe Pharma America, Inc., today announced RADICAVA ™ (edaravone), an intravenous therapy indicated for all adult patients diagnosed with amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease, is now available for treatment in the United States. RADICAVA, …

ALS Ice Bucket Challenge: Three Years Later

In 2014, the ALS Ice Bucket Challenge swept the globe, forever changing the face of ALS. Millions of dollars were raised and awareness reached an all time high. Three years later, major advances in ALS research and patient care have …